Share Purchase Plan Results
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Atomo Diagnostics Ltd. has announced the results of its Share Purchase Plan, confirming the closure of the plan and the number of shares raised. The company received valid applications for a significant number of shares, raising funds before costs and will issue free attaching options to the applicants. Managing Director John Kelly expressed gratitude to shareholders for their participation, indicating a strong position for future operations.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Atomo Diagnostics
- Response to ASX Aware Letter
- Atomo Completes Capital Raise
- FebriDx FDA CLIA wavier approval unlocks upside for Pascal
- Trading Halt
- Pause in Trading
Later from Atomo Diagnostics
- Managing Director & CEO Transition
- 2026 Appendix 4E and Annual Report
- Atomo Signs Agreement with Innovation Scientific
- Quarterly Activities/Appendix 4C Cash Flow Report
- Q1 FY27 Results Presentation
Follow Atomo Diagnostics into a list and get an email when it puts out news.
Follow Atomo Diagnostics